Literature DB >> 10337950

Expression of tissue type and urokinase type plasminogen activators as well as plasminogen activator inhibitor type-1 and type-2 in human and rhesus monkey placenta.

Z Y Hu1, Y X Liu, K Liu, S Byrne, T Ny, Q Feng, C D Ockleford.   

Abstract

The distribution of mRNAs and antigens of tissue type (t) and urokinase type (u) plasminogen activators (PA) plus their corresponding inhibitors, type-1 (PAI-1) and type-2 (PAI-2) were studied in human and rhesus monkey placentae by in situ hybridisation and immunocytochemistry. Specific monkey cRNA and antibodies against human tPA, uPA, PAI-1 and PAI-2 were used as probes. The following results were obtained. (1) All the molecules tPA, uPA, PAI-1 and PAI-2 and their mRNAs were identified in the majority of the extravillous cytotrophoblast cells of the decidual layer between Rohr's and Nitabuch's striae and in cytotrophoblast cells of the chorionic plate, basal plate, intercotyledonary septae and cytotrophoblast cells of the chorionic villous tree. (2) Expression of uPA and PAI-2 was noted in villous trophoblast whereas tPA and PAI-1 were mainly concentrated where detachment from maternal tissue occurs. (3) No expression of tPA, uPA, PAI-1 and PAI-2 was observed in the basal plate endometrial stromal cells, chorionic plate connective tissue cells, septal endometrial stromal cells or villous core mesenchyme. (4) The distribution of probes observed following in situ hybridisation is generally consistent with the immunofluorescence pattern of the corresponding antigens and no significant interspecies differences were noted. It is possible that both decidual and extravillous trophoblast cells of placentae of human and rhesus monkey are capable of producing tPA, uPA, PAI-1 and PAI-2 to differing extents. Coordinated expression of these genes in the tissue may play an essential role in the maintenance of normal placentation and parturition. The differences in distribution we observed are consistent with the suggestion that coordinated expression of tPA and its inhibitor PAI-1 may play a key role in fibrinolytic activity in the early stages of placentation and separation of placenta from maternal tissue at term. On the other hand, uPA with its inhibitor PAI-2 appears mainly to play a role in degradation of trophoblast cell-associated extracellular matrix, and thus may be of greatest importance during early stages of placentation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10337950      PMCID: PMC1467912          DOI: 10.1046/j.1469-7580.1999.19420183.x

Source DB:  PubMed          Journal:  J Anat        ISSN: 0021-8782            Impact factor:   2.610


  41 in total

Review 1.  Plasminogen activation and regulation of pericellular proteolysis.

Authors:  O Saksela
Journal:  Biochim Biophys Acta       Date:  1985-11-12

2.  Different types of plasminogen activator inhibitors in plasma and platelets in pregnant women.

Authors:  I M Nilsson; P Felding; I Lecander; C Lennér; B Astedt
Journal:  Br J Haematol       Date:  1986-02       Impact factor: 6.998

3.  Urokinase inhibitor in human placenta.

Authors:  T Kawano; K Morimoto; Y Uemura
Journal:  Nature       Date:  1968-01-20       Impact factor: 49.962

4.  Degradation of extracellular matrix by the trophoblastic cells of first-trimester human placentas.

Authors:  S J Fisher; M S Leitch; M S Kantor; C B Basbaum; R H Kramer
Journal:  J Cell Biochem       Date:  1985       Impact factor: 4.429

5.  Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli.

Authors:  D Pennica; W E Holmes; W J Kohr; R N Harkins; G A Vehar; C A Ward; W F Bennett; E Yelverton; P H Seeburg; H L Heyneker; D V Goeddel; D Collen
Journal:  Nature       Date:  1983-01-20       Impact factor: 49.962

6.  Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane.

Authors:  L A Liotta; R H Goldfarb; R Brundage; G P Siegal; V Terranova; S Garbisa
Journal:  Cancer Res       Date:  1981-11       Impact factor: 12.701

7.  The fibrinolytic system in pre-eclampsia.

Authors:  L Gow; D M Campbell; D Ogston
Journal:  J Clin Pathol       Date:  1984-01       Impact factor: 3.411

8.  Plasminogen activator production by trophoblast cells in vitro: effect of steroid hormones and protein synthesis inhibitors.

Authors:  O Martin; F Arias
Journal:  Am J Obstet Gynecol       Date:  1982-02-15       Impact factor: 8.661

9.  Identification and primary sequence of an unspliced human urokinase poly(A)+ RNA.

Authors:  P Verde; M P Stoppelli; P Galeffi; P Di Nocera; F Blasi
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

10.  Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors.

Authors:  E K Kruithof; C Tran-Thang; A Gudinchet; J Hauert; G Nicoloso; C Genton; H Welti; F Bachmann
Journal:  Blood       Date:  1987-02       Impact factor: 22.113

View more
  11 in total

Review 1.  Extracellular nucleic acids in maternal circulation as potential biomarkers for placental insufficiency.

Authors:  Ilona Hromadnikova
Journal:  DNA Cell Biol       Date:  2012-02-24       Impact factor: 3.311

2.  Expression of matrix metalloproteinase-2, tissue inhibitors of metalloproteinase-1, -3 at the implantation site of rhesus monkey during the early stage of pregnancy.

Authors:  F Gao; X L Chen; P Wei; H J Gao; Y X Liu
Journal:  Endocrine       Date:  2001-10       Impact factor: 3.633

3.  Tissue kallikrein in human placenta in early and late gestation.

Authors:  G Valdés; C Chacón; J Corthorn; C D Figueroa; A M Germain
Journal:  Endocrine       Date:  2001-03       Impact factor: 3.633

Review 4.  Role of platelets in placentation.

Authors:  Yukiyasu Sato; Hiroshi Fujiwara; Ikuo Konishi
Journal:  Med Mol Morphol       Date:  2010-09-21       Impact factor: 2.309

5.  The efficacy of metformin in pregnant women with polycystic ovary syndrome: a meta-analysis of clinical trials.

Authors:  J Zheng; P F Shan; W Gu
Journal:  J Endocrinol Invest       Date:  2013-04-12       Impact factor: 4.256

6.  Estrogen-induced uterine abnormalities in TIMP-1 deficient mice are associated with elevated plasmin activity and reduced expression of the novel uterine plasmin protease inhibitor serpinb7.

Authors:  Xuan Zhang; Etter Hoang; Warren B Nothnick
Journal:  Mol Reprod Dev       Date:  2009-02       Impact factor: 2.609

7.  Effects of prenatal tobacco exposure on gene expression profiling in umbilical cord tissue.

Authors:  Naveed Hussain; Winfried Krueger; Jonathan Covault; Stephen Walsh; Henry R Kranzler; Cheryl Oncken
Journal:  Pediatr Res       Date:  2008-08       Impact factor: 3.756

8.  Autoantibodies to plasminogen and tissue plasminogen activator in women with recurrent pregnancy loss.

Authors:  C Bu; C Zhang; Z Li; L Gao; Z Xie; G Cai
Journal:  Clin Exp Immunol       Date:  2007-04-11       Impact factor: 4.330

9.  Spatiotemporal expression of the serine protease inhibitor, SERPINE2, in the mouse placenta and uterus during the estrous cycle, pregnancy, and lactation.

Authors:  Schu-Rern Chern; Sheng-Hsiang Li; Chung-Hao Lu; Edmund I Tsuen Chen
Journal:  Reprod Biol Endocrinol       Date:  2010-10-27       Impact factor: 5.211

Review 10.  Role of Plasminogen Activator Inhibitor Type 1 in Pathologies of Female Reproductive Diseases.

Authors:  Yao Ye; Aurelia Vattai; Xi Zhang; Junyan Zhu; Christian J Thaler; Sven Mahner; Udo Jeschke; Viktoria von Schönfeldt
Journal:  Int J Mol Sci       Date:  2017-07-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.